These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vasculitides with cutaneous expression in children: clinico-pathological correlations. Borroni G; Grassi S; Carugno A G Ital Dermatol Venereol; 2015 Feb; 150(1):51-71. PubMed ID: 25516220 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous vasculitis: insights into pathogenesis and histopathological features. Cassisa A; Cima L Pathologica; 2024 Apr; 116(2):119-133. PubMed ID: 38767544 [TBL] [Abstract][Full Text] [Related]
5. Cytokines, fibrinolysis and vasculitis. Teofoli P; Lotti T Int Angiol; 1995 Jun; 14(2):125-9. PubMed ID: 8609438 [TBL] [Abstract][Full Text] [Related]
6. The role of regulatory peptides in the pathogenesis of cutaneous necrotizing vasculitis. Hautmann G; Lotti T Int Angiol; 1995 Jun; 14(2):138-50. PubMed ID: 8609440 [TBL] [Abstract][Full Text] [Related]
15. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases]. Shilkina NP; Butusova SV; Driazhenkova IV Angiol Sosud Khir; 2014; 20(1):27-34. PubMed ID: 24722018 [TBL] [Abstract][Full Text] [Related]
18. The role of the endothelium in systemic vasculitis. Savage CO; Cooke SP J Autoimmun; 1993 Apr; 6(2):237-49. PubMed ID: 8499061 [TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers of endothelial cell activation: candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals. Zhang J; Hanig JP; De Felice AF Vascul Pharmacol; 2012; 56(1-2):14-25. PubMed ID: 21968053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]